Haemonetics

Yahoo Finance • 8 days ago

TomTom signs multi-year agreement to deliver traffic services to Hyundai AutoEver’s navigation for European vehicle lineup

Hyundai AutoEver (HAE) and TomTom expand their partnership to equip vehicles across Europe with TomTom technology. TomTom Real-Time Traffic and Speed Camera Service to enhance HMG drivers’ in-dash navigation experience. AMSTERDAM, Oct. 0... Full story

Yahoo Finance • 22 days ago

Haemonetics Corporation (HAE) Launches PerQseal Elite, Advancing Minimally Invasive Vascular Care

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Haemonetics Corporation is one of them. Haemonetics Corporation (NYSE:HAE), a global leader in blood and plasma management technologies, c... Full story

Yahoo Finance • 30 days ago

RSI Alert: Haemonetics (HAE) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the R... Full story

Yahoo Finance • 2 months ago

Mizuho lowers Haemonetics stock price target to $70 on VASCADE MVP slowdown

Investing.com - Mizuho lowered its price target on Haemonetics (NYSE:HAE) to $70.00 from $90.00 on Thursday, while maintaining an Outperform rating on the stock. According to InvestingPro analysis, the company appears undervalued at curren... Full story

Yahoo Finance • 2 months ago

Chuck Royce's Strategic Moves: A Closer Look at Kennedy-Wilson Holdings Inc.

Exploring the Latest 13F Filing and Investment Strategies Chuck Royce (Trades, Portfolio) recently submitted the 13F filing for the second quarter of 2025, providing insights into his investment moves during this period. Charles M. Royce... Full story

Yahoo Finance • 2 months ago

Notable Two Hundred Day Moving Average Cross - HAE

In trading on Friday, shares of Haemonetics Corp. (Symbol: HAE) crossed below their 200 day moving average of $75.69, changing hands as low as $75.59 per share. Haemonetics Corp. shares are currently trading off about 1.6% on the day. Th... Full story

Yahoo Finance • 2 months ago

GVS H1 2025 presentation: EBITDA margins reach post-pandemic high despite mixed sales

Introduction & Market Context Italian filtration specialist GVS SpA presented its H1 2025 results on August 7, 2025, highlighting improved profitability metrics despite modest overall sales growth. The company’s stock traded at €4.98 on p... Full story

Yahoo Finance • 2 months ago

Haemonetics earnings beat by $0.09, revenue topped estimates

Investing.com - Haemonetics (NYSE: HAE) reported first quarter EPS of $1.10, $0.09 better than the analyst estimate of $1.01. Revenue for the quarter came in at $321.39M versus the consensus estimate of $302.62M. Haemonetics’s stock price... Full story

Yahoo Finance • 2 months ago

How The Pieces Add Up: SPMD Targets $63

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied... Full story

Yahoo Finance • 2 months ago

Haemonetics Builds Momentum with New Buy Rating and Growth Promise

Haemonetics Corporation (NYSE:HAE) is one of the 11 Best Long Term Low Risk Stocks to Invest in. The company’s stocks are upgraded to Buy despite a 9% decline in revenue, reported in the Q4 earnings call.Haemonetics Builds Momentum with N... Full story

Yahoo Finance • 3 months ago

Lantheus, ICU Medical, Haemonetics, CONMED, and Astrana Health Shares Plummet, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned negative after the White... Full story

Yahoo Finance • 3 months ago

Citi adjusts MedTech outlook: Bullish on Haemonetics, bearish on Tandem Diabetes

Investing.com -- Citi analysts have taken action on two U.S. MedTech names, upgrading Haemonetics (NYSE:HAE) to Buy from Neutral, while downgrading Tandem Diabetes Care (NASDAQ:TNDM) to Sell/High Risk from Neutral/High Risk, citing divergi... Full story

Yahoo Finance • 3 months ago

Analysts Predict 15% Gains Ahead For IJJ

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied... Full story

Yahoo Finance • 4 months ago

Baird initiates Haemonetics stock with outperform rating on market position

Investing.com - Baird initiated coverage on Haemonetics (NYSE:HAE) Wednesday with an outperform rating and set a price target of $87.00. The company, currently trading at $73.40, has demonstrated strong financial health with a return on eq... Full story

Yahoo Finance • 4 months ago

The past five years for Haemonetics (NYSE:HAE) investors has not been profitable

While it may not be enough for some shareholders, we think it is good to see the Haemonetics Corporation (NYSE:HAE) share price up 12% in a single quarter. But if you look at the last five years the returns have not been good. You would ha... Full story

Yahoo Finance • 6 months ago

Is Haemonetics Corporation (HAE) the Best Russell 2000 Stock to Buy According to Wall Street Analysts?

We recently published a list of 11 Best Russell 2000 Stocks to Buy According to Wall Street Analysts. In this article, we are going to take a look at where Haemonetics Corporation (NYSE:HAE) stands against other best Russell 2000 stocks to... Full story

Yahoo Finance • 6 months ago

Medical Devices & Supplies - Specialty Stocks Q4 Teardown: Integer Holdings (NYSE:ITGR) Vs The Rest

Medical Devices & Supplies - Specialty Stocks Q4 Teardown: Integer Holdings (NYSE:ITGR) Vs The Rest Let’s dig into the relative performance of Integer Holdings (NYSE:ITGR) and its peers as we unravel the now-completed Q4 medical devices &... Full story

Yahoo Finance • 6 months ago

3 Stocks That May Be Trading Below Their Estimated Value In April 2025

As the United States stock market navigates a period of volatility amid President Trump's anticipated announcement on new tariffs, major indices like the Dow Jones and S&P 500 have shown resilience with recent gains despite earlier decline... Full story

Yahoo Finance • 8 months ago

3 US Stocks Estimated To Be Trading Below Their Intrinsic Values

In a week marked by significant declines across major U.S. indices, with the Dow experiencing its worst performance since October and the Nasdaq facing its largest drop in three months, investors are keenly searching for opportunities amid... Full story

Yahoo Finance • 8 months ago

3 US Stocks That May Be Trading Below Their Estimated Value

As the U.S. stock market navigates a mixed landscape, with major indices showing varied movements and recent selloffs impacting investor sentiment, opportunities may arise for those looking to identify stocks that are trading below their e... Full story